Clinical trial

Filgotinib Effect on Proteomic Profile and Micro-RNA Expression in Patients With Active Rheumatoid Arthritis (RA)

NCT06527534

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2024-07-15

PhasePHASE4

Study timeline

Study start (actual)2024-07-15Date precision: day

Registry last updated2024-08-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

FilgotinibDRUG

AdalimumabDRUG · verified · RxNorm: adalimumab

Sponsors & collaborators

Universita di Veronalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06527534 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.